ArticleThe Journal of infection2022

EK1 with dual Q1004E/N1006I mutation: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2.

Fangfang Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.